Observation of Pyrimethamine (Daraprim) as a Suppressant of Malaria in a Small Village in Jordan

View More View Less
  • Cooperative Department for Health and Sanitation U. S. Operations Mission to Jordan and the Ministry of Health, Government of Jordan

Summary

Pyrimethamine (Daraprim) in doses of 25 mg. per adult, was administered weekly to 110 individuals living in a small malarial endemic village in Jordan. One hundred and twenty other individuals living in the same village who served as the control group received placebos. During the 18-week period of the study (June 20 to October 24, 1954), 25 of the control group developed malaria (P. vivax) whereas no cases of malaria occurred among the pyrimethamine treated individuals.

Author Notes

Senior Scientist (R), Division of International Health, U. S. Public Health Service; Parasitologist, University of Hawaii.

Assistant Parasitologist, Central Government Laboratory, Amman, Jordan.

Save